“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Zenas BioPharma
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Zenas BioPharma (Nasdaq: ZBIO) is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients in need. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimabs mechanism of action and chronic dosing regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease
| C-Level 7 | VP - Level16 |
| Director50 | Manager19 |
| Others43 | |
| Structure | Email Format |
|---|---|
| <first><l>@ |
John |
| <first>@ | John@neuroinstitute.mx |
| <last><first>@ | SmithJohn@neuroinstitute.mx |
| <first>.<l>@ |
John. |
| <first>.<last>@ | John.Smith@neuroinstitute.mx |
| Pain Points | Locations | Technologies |
|---|---|---|
| Application Development | Waltham, MA | inventory management, continuous improvement, security, serialization, packaging, change management, quality assurance, communication, data analysis, compliance, sql, share, scope, r, operating procedures, data science, operations, python, financial, e, risk, collaboration |
| Artificial Intelligence | Waltham, MA | inventory management, continuous improvement, security, serialization, packaging, change management, quality assurance, communication, data analysis, compliance, sql, share, scope, r, operating procedures, data science, operations, python, financial, e, risk, collaboration |
| Build & Release | Waltham, MA | quality assurance, communication, compliance, collaboration, share, operations |
| Business process management | Waltham, MA | inventory management, continuous improvement, security, serialization, packaging, change management, quality assurance, communication, data analysis, compliance, sql, share, scope, r, operating procedures, data science, operations, python, financial, e, risk, collaboration |
| Compliance | Waltham, MA | inventory management, continuous improvement, security, serialization, packaging, change management, quality assurance, communication, data analysis, compliance, sql, share, scope, r, operating procedures, data science, operations, python, financial, e, risk, collaboration |
Zenas BioPharma looking to hire in Application Development in Shanghai, Shanghai, China
Zenas BioPharma looking to hire in Artificial Intelligence in Shanghai, Shanghai, China
Zenas BioPharma looking to hire in Artificial Intelligence in Waltham, MA
Gcp
Access
Board
Buildout
Director
Agile
Acceptance testing
Access management
Analytics
Archival
Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...
View MoreZenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...
View MoreZenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...
View MoreZenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...
View MoreZenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...
View MoreZenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...
View MoreZenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...
View MoreZenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...
View MoreInvesting.com - H.C. Wainwright has reiterated a Buy rating and $30.00 price target on Zenas Biopharma (NASDAQ:ZBIO), currently trading at $25.90,
Read MoreZenas BioPharma (ZBIO) and Royalty Pharma (RPRX) announced that Royalty Pharma will provide up to $300M in funding in exchange for a royalty on sal
Read MoreZenas BioPharma, Inc. ( NASDAQ:ZBIO ) insiders who purchased shares in the last 12 months were richly rewarded last
Read MoreBiotech funding agreement includes $75M upfront plus $225M in milestone payments. Phase 3 IgG4-RD trial results expected year-end, with potential FDA
Read MoreZenas BioPharma (Nasdaq: ZBIO) is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients in need. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated...
Autoimmune diseases and immunology
Zenas biopharma operates in the Biotechnology research industry.
Zenas biopharma's revenue is $670.00k
Zenas biopharma has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.